The Pharma industry has stayed flat over the last week. As for the the longer term, the industry is up 19% over the past 12 months. Earnings are forecast to grow by 28% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 28 Jun 2024 | US$2.0t | US$357.6b | US$14.0b | 16x | 140.2x | 5.5x |
Sun, 26 May 2024 | US$1.9t | US$358.3b | US$14.1b | 17.9x | 133.7x | 5.2x |
Tue, 23 Apr 2024 | US$1.8t | US$357.7b | US$29.8b | 20.6x | 59.9x | 5x |
Thu, 21 Mar 2024 | US$1.9t | US$355.4b | US$22.5b | 20.2x | 83.9x | 5.3x |
Sat, 17 Feb 2024 | US$1.9t | US$355.0b | US$23.9b | 28.3x | 78.6x | 5.3x |
Mon, 15 Jan 2024 | US$1.8t | US$375.2b | US$33.9b | 26.3x | 52.6x | 4.7x |
Wed, 13 Dec 2023 | US$1.7t | US$375.1b | US$33.9b | 26.7x | 48.9x | 4.4x |
Fri, 10 Nov 2023 | US$1.7t | US$375.2b | US$34.0b | 26.2x | 49.1x | 4.5x |
Sun, 08 Oct 2023 | US$1.7t | US$381.8b | US$43.8b | 18.5x | 38.2x | 4.4x |
Tue, 05 Sep 2023 | US$1.7t | US$381.4b | US$43.7b | 19.6x | 39.7x | 4.5x |
Thu, 03 Aug 2023 | US$1.7t | US$379.1b | US$44.0b | 18.7x | 38.5x | 4.5x |
Sat, 01 Jul 2023 | US$1.8t | US$392.8b | US$60.2b | 18.7x | 29.2x | 4.5x |
Mon, 29 May 2023 | US$1.7t | US$392.9b | US$60.6b | 17.8x | 27.6x | 4.3x |
Wed, 26 Apr 2023 | US$1.7t | US$402.7b | US$63.2b | 17.2x | 26.3x | 4.1x |
Fri, 24 Mar 2023 | US$1.5t | US$401.1b | US$69.3b | 15.3x | 22.2x | 3.8x |
Sun, 19 Feb 2023 | US$1.6t | US$401.8b | US$68.4b | 18.8x | 23.9x | 4.1x |
Tue, 17 Jan 2023 | US$1.7t | US$403.7b | US$70.7b | 17.6x | 24.6x | 4.3x |
Thu, 15 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 16.9x | 25.3x | 4.4x |
Sat, 12 Nov 2022 | US$1.7t | US$403.6b | US$71.1b | 12.9x | 23.6x | 4.2x |
Mon, 10 Oct 2022 | US$1.5t | US$403.0b | US$71.3b | 12.2x | 21.7x | 3.8x |
Wed, 07 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 14x | 21.9x | 3.9x |
Fri, 05 Aug 2022 | US$1.6t | US$405.5b | US$70.1b | 21.2x | 23.2x | 4x |
Sun, 03 Jul 2022 | US$1.7t | US$392.6b | US$65.1b | 22.3x | 26x | 4.3x |
Tue, 31 May 2022 | US$1.7t | US$392.5b | US$64.8b | 22x | 26.4x | 4.4x |
Thu, 28 Apr 2022 | US$1.6t | US$374.7b | US$59.8b | 20.8x | 27.4x | 4.4x |
Sat, 26 Mar 2022 | US$1.6t | US$373.8b | US$60.3b | 22.3x | 27.3x | 4.4x |
Mon, 21 Feb 2022 | US$1.5t | US$373.4b | US$59.2b | 21.1x | 25.7x | 4.1x |
Wed, 19 Jan 2022 | US$1.6t | US$361.3b | US$37.7b | 23.2x | 42.1x | 4.4x |
Fri, 17 Dec 2021 | US$1.7t | US$361.1b | US$38.1b | 22.7x | 43.8x | 4.6x |
Sun, 14 Nov 2021 | US$1.6t | US$360.6b | US$38.5b | 24.3x | 41.6x | 4.4x |
Tue, 12 Oct 2021 | US$1.5t | US$337.7b | US$24.8b | 20.2x | 60x | 4.4x |
Thu, 09 Sep 2021 | US$1.5t | US$338.7b | US$25.4b | 17.5x | 60.4x | 4.5x |
Sat, 07 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 20.5x | 61.1x | 4.7x |
73.2x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.26% | |
Healthcare | 0.11% | |
Pharma | 0.98% | |
Pharma | 0.98% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$909.04 | 2.6% +US$20.8b | 95.7% | PE133.3x | |
ZTS Zoetis | US$176.46 | 4.9% +US$3.8b | 2.7% | PE33.7x | |
BMY Bristol-Myers Squibb | US$41.51 | 1.1% +US$952.7m | -35.1% | PS1.8x | |
MRK Merck | US$129.82 | 0.1% +US$379.9m | 14.3% | PE142.6x | |
PFE Pfizer | US$27.80 | 0.2% +US$340.0m | -23.0% | PS2.9x |